Unknown

Dataset Information

0

Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia.

ABSTRACT:

SUBMITTER: Konishi Y 

PROVIDER: S-EPMC8654583 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Transcriptomics Gene expression signature of bone lesion waldenstrom macroglobulinemia and myeloma
2020-07-06 | GSE70515 | GEO
Unknown Waldenstrom macroglobulinemia treatment algorithm 2018.
| S-EPMC5928091 | biostudies-literature
Unknown Thalidomide and rituximab in Waldenstrom macroglobulinemia.
| S-EPMC2597120 | biostudies-literature
Unknown Management of Waldenstrom macroglobulinemia in 2020.
| S-EPMC7727571 | biostudies-literature
Unknown Development and characterization of a novel human Waldenstrom macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenstrom Macroglobulinemia 1.
| S-EPMC4406272 | biostudies-literature
Unknown microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
| S-EPMC2938840 | biostudies-other
Unknown Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.
| S-EPMC8646558 | biostudies-literature
Unknown New developments in the management of Waldenstrom macroglobulinemia.
| S-EPMC5354523 | biostudies-literature
Unknown Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.
| S-EPMC8064747 | biostudies-literature
Unknown Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
| S-EPMC1895596 | biostudies-literature